Skip to contentT
Thermo Fisher Scientific Inc.
T
TMOThermo Fisher Scientific Inc. Q3 2021 · 10-Q
Revenue$9.33B$9.33B+9.5% vs Q3 2020 Net Income$1.90B$1.90Bno prior Q3 2020 on file EPS Diluted$4.79$4.79−1.0% vs Q3 2020 Operating Income$2,278,000,000−6.1% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Thermo Fisher Scientific Inc. · CIK 97745 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$2,126,000,000−9.2% Margins · derivedOperating margin24.4%−4.1 pt vs Q3 2020
Net margin20.4%
ended Oct 2, 2021 · filed Nov 4, 2021 · 33 d after period end